English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Contrast-induced nephropathy (CIN) is an injury to the kidney as a result of exposure to intravascular iodinated contrast medium. It represents an increasing health care burden and challenge as the frequency of diagnostic imaging and interventional studies increase, particularly among populations at risk of developing CIN. As the population ages, decreased renal function and increased atherosclerotic cardiovascular disease become more prevalent. An increasing incidence of obesity with resultant metabolic syndrome and/or type 2 diabetes mellitus also increases the population at risk for CIN (Toprak et al., 2006). Coronary artery disease is a major complication of type 2 diabetes mellitus. Thus, patients with type 2 diabetes mellitus often require coronary angiography and coronary intervention and are at risk of CIN.

Contrast-Induced Nephropathy in Patients with Type 2 Diabetes Mellitus and Coronary Artery Disease: Update and Practical Clinical Applications